Developing a new treatment for Canavan Disease using NAT8L inhibitors
Official title: Development of NAT8L inhibitors for the Treatment of Canavan Disease
Funded at Johns Hopkins University · NIH-10872391 · Data updated 2026-11-12
This study is looking at a new treatment for Canavan Disease, a condition that affects how children's brains develop, and aims to create a medicine that can help reduce harmful substances in the brain to improve their thinking and movement skills.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $396,324 |
| NIH project number | 1R61NS136652-01 |
| Project ID | NIH-10872391 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children under 11 years old diagnosed with Canavan Disease.
✕Less likely to help
Patients with other neurological disorders or those over the age of 11 may not benefit from this research.
What this research studies
This research focuses on Canavan Disease, a genetic disorder that affects brain development and function in children. The team is working to develop NAT8L inhibitors that can penetrate the blood-brain barrier and reduce harmful levels of N-acetylaspartate (NAA) in the brain, which are responsible for the disease's symptoms. By optimizing a promising compound identified through high-throughput screening, the researchers aim to create an effective therapy that could improve cognitive and motor functions in affected patients.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking treatment that alleviates the symptoms of Canavan Disease and improves the quality of life for patients.
How similar studies have gone: Previous research has shown promising results in animal models using similar approaches, indicating potential for success in human applications.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Tsukamoto, Takashi — Johns Hopkins University
- Study coordinator: Tsukamoto, Takashi
Related research
Other NIH-funded projects on the same topics.
-
Targeting hidden brain injuries in iTTP to improve long-term brain health
A researcher aims to find out how silent brain injuries in people with immune thrombotic thrombocytopenic purpura (iTTP) happen, how they affect thinking and stroke risk, and how to prevent them.
-
Accelerated flap coverage for severe leg injuries: earlier reconstruction vs standard timing
This study tests whether doing early flap coverage after a severe leg injury lowers infection risk and improves healing for patients with open wounds and bone injury.
-
Placebo-controlled shunting for iNPH: does the surgery help with walking and balance?
A doctor-led trial at Johns Hopkins will test whether a shunt surgery improves walking and balance in older adults with idiopathic normal pressure hydrocephalus.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
Johns Hopkins Total Worker Health Center focusing on mental health
A nationwide center at Johns Hopkins is working to improve mental health and well-being among workers by studying workplace health strategies and translating findings into practical tools.
-
Role of fat droplets in liver fat and inflammatory signals in NAFLD
A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.